Subordinate effect of -21M HLA-B dimorphism on NK cell repertoire diversity and function in HIV-1 infected individuals of African origin by Cubero, EM, Ogbe, A, Cohen, MS, Haynes, BF, Borrow, P

Affinity maturation pathway of an anti-MPER neutralizing mAb, CAP206-CH12 by Tumba NL, Gray ES, Lambson BE, Karim SS, Liao H, Haynes BF, Alam M, Morris L

P20-17. Evolution of multiple transmitted viruses during the early stage of HIV-1 infection by McMichael A, Goonetilleke N, Keele B, Pavlicek J, Chen S, Hopper J, Kirchherr JL, Haynes BF, Gao F

P04-44. Generation of antibody responses to HIV-1 membrane proximal external region (MPER) antigen by Haynes BF, Liao H, Alam M, Moody MA, Verkoczy L, Liao D, Kuraoka M, Holl TM, Kelsoe GH

Apoptotic microparticles generated during acute HIV-1 infection inhibit human dendritic cells via CD44 by Frleta D, Ochoa CE, Kramer HB, Khan SA, Stacey AR, Borrow P, Kessler BM, Haynes BF, Bhardwaj N

P04-26. Immunological tolerance prevents the expression of a broadly reactive neutralizing HIV-1 antibody by Kelsoe G, Liao H, Alam SM, Ouyang Y, Bouton-Verville H, Holl TM, Diaz M, Verkoczy L, Haynes BF

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies by Haynes, BF, Wiehe, K, Borrow, P, Saunders, KO, Korber, B, Wagh, K, McMichael, AJ, Kelsoe, G, Hahn, BH, Alt, F, Shaw, GM

Detection of antibodies to the α4β7 integrin binding site on HIV-1 gp120 V2 loop using a novel cell adhesion assay by Rao M, Karasavvas N, Pinter A, Liao H, Bonsignori M, Mathieson B, Zolla-Pazner S, Haynes BF, Michael NL, Kim JH, Alving CR, Peachman KK

Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein by Alexander J, Gurwith M, Mendy J, Vang L, Manayani D, Avanzini J, Guenther B, Farness P, Haynes BF, Liao H, Montefiori DC, LaBranche CC, Mayall T

P04-54 LB. Genetic signature analysis identifies the CD4i region of gp120 as a determinant of broadly NAb responses in HIV-1-infected individuals by Haynes BF, Seaman M, Gao H, Greene K, Tang H, Li M, Kumar A, Gao F, Lapedes A, Daniels M, Bhattacharya T, Gnanakaran G, Montefiori DC, Korber BT

Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth by Roskin, KM, Jackson, KJL, Lee, JY, Hoh, RA, Joshi, SA, Hwang, KK, Bonsignori, M, Pedroza-Pacheco, I, Liao, HX, Moody, MA, Fire, AZ, Borrow, P, Haynes, BF, Boyd, SD

A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies by Doria-Rose NA, Georgiev I, Staupe RP, O'Dell S, Chuang G, Gorman J, McLellan JS, Pancera M, Bonsignori M, Haynes BF, Burton DR, Koff WC, Kwong PD, Mascola JR

HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies by Labranche, CC, McGuire, AT, Gray, MD, Behrens, S, Zhou, T, Sattentau, QJ, Peacock, J, Eaton, A, Greene, K, Gao, H, Tang, H, Perez, LG, Saunders, KO, Mascola, JR, Haynes, BF, Stamatatos, L, Montefiori, DC

Lack of IgA envelope-reactive antibody producing cells in terminal ileum in early and chronic HIV-1 infection by Trama AM, Liao H, Foulger A, Marshall DJ, Whitesides JF, Parks R, Meyerhoff R, Lloyd KE, Donathan M, Lucas J, Soderberg K, Kepler TB, Vandergrift N, Yates N, Tomaras GD, Moody MA, Haynes BF

Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells by Parker, R, Partridge, T, Wormald, C, Kawahara, R, Stalls, V, Aggelakopoulou, M, Parker, J, Powell Doherty, R, Ariosa Morejon, Y, Lee, E, Saunders, K, Haynes, BF, Acharya, P, Thaysen-Andersen, M, Borrow, P, Ternette, NMN

Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene family by Bonsignori M, Pollara J, Moody MA, Kepler TB, Chen X, Gurley TC, Kozink DM, Marshall DJ, Whitesides JF, Kaewkungwal J, Nitayaphan S, Pitisuttithum P, Rerks-Ngarm S, Kim JH, Michael NL, Montefiori DC, Liao H, Ferrari G, Haynes BF

Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial by Campion, SL, Brenna, E, Thomson, E, Fischer, W, Ladell, K, McLaren, JE, Price, DA, Frahm, N, McElrath, JM, Cohen, KW, Maenza, JR, Walsh, SR, Baden, LR, Haynes, BF, Korber, B, Borrow, P, McMichael, AJ

Temporal dynamics of CD8+ T cell effector responses during primary HIV infection. by Demers, KR, Makedonas, G, Buggert, M, Eller, MA, Ratcliffe, SJ, Goonetilleke, N, Li, CK, Eller, LA, Rono, K, Maganga, L, Nitayaphan, S, Kibuuka, H, Routy, J-P, Slifka, MK, Haynes, BF, McMichael, AJ, Bernard, NF, Robb, ML, Betts, MR

RAB11FIP5-deficient mice exhibit cytokine-related transcriptomic signatures by Li, D, Bradley, T, Cain, DW, Pedroza-Pacheco, I, Aggelakopoulou, M, Parks, R, Barr, M, Xia, S-M, Scearce, R, Bowman, C, Stevens, G, Newman, A, Hora, B, Chen, Y, Riebe, K, Wang, Y, Sempowski, G, Saunders, KO, Borrow, P, Haynes, BF

S021-04 OA. A large-scale analysis of immunoglobulin sequences derived from plasmablasts/plasma cells in acute HIV-1 infection subjects by Markowitz M, Margolis DM, Shea TC, Kelsoe GH, Moody MA, Tomaras GD, Gao F, Yang Y, Marshalls DJ, Whitesides JF, Amos J, Parks R, Derosa K, Nagel A, Chen X, Dixon A, Liao H, Munshaw S, Goepfert P, Shaw G, Haynes BF, Kepler TB